Four key questions surrounding thrombolytic therapy for submassive pulmonary embolism. Review uri icon

Overview

abstract

  • Submassive pulmonary embolism (PE) remains a vexing entity, and the appropriate use of thrombolytic therapy for this subgroup continues to be actively debated. Catheter-directed thrombolysis has shown efficacy for submassive PE and is gaining momentum because of theoretically improved safety. This review poses and responds to four questions that explore the complex issues surrounding optimal therapy of submassive PE.

publication date

  • November 12, 2015

Research

keywords

  • Fibrinolytic Agents
  • Pulmonary Artery
  • Pulmonary Embolism
  • Thrombolytic Therapy

Identity

Scopus Document Identifier

  • 84956559602

Digital Object Identifier (DOI)

  • 10.1177/1358863X15614388

PubMed ID

  • 26566660

Additional Document Info

volume

  • 21

issue

  • 1